Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

A 78-year-old man with Cronkhite-Canada syndrome improved significantly after treatment and remains symptom-free.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Different races and genders have unique skin and hair issues, requiring specialized care and more research for effective treatment.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Trilostane helped a cat with a hormone issue but the cat later died from a kidney infection.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The document concludes that early recognition and appropriate treatment of red scalp, red ear, and red scrotum syndromes can lead to remission.

Hormonal contraceptives and therapies regulate organ functions and treat various conditions.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Vitiligo is a skin condition causing white patches, likely due to an autoimmune issue.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.